Ncardia’s iPSC-derived microglia may aid ALS research and help to screen new therapies that target inflammation in ALS.
ALS is a disease of continual losses and trade-offs. We walk a tightrope between safety and independence, and caution and quality of life.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback